Ghent University Academic Bibliography

Journal Article
open access

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial.

V C M Geurts, L Voorwerk, S Balduzzi, R Salgado, Koen Van de Vijver (UGent) , M G J van Dongen, I Kemper, I A M Mandjes, M Heuver, W Sparreboom, et al.

(2023) Breast (Edinburgh, Scotland). 70. p.76-81

Add to list

Journal Article
A1
open access

Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial

Vincent Vakaet (UGent) , Hans Vanhulle, Koen Van de Vijver (UGent) , Ingeborg Hilderson, Eline Naert (UGent) , Wilfried De Neve (UGent) , Jo Van Dorpe (UGent) , An Hendrix (UGent) , Menekse GOKER (UGent) , Herman Depypere (UGent) , et al.

(2022) BREAST. 62. p.10-15

Add to list

Journal Article
A1
open access

Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost

Hans Van Hulle, Vincent Vakaet (UGent) , Christel Monten (UGent) , Pieter Deseyne (UGent) , Max Schoepen (UGent) , Cato Colman, Leen Paelinck (UGent) , Annick Van Greveling (UGent) , Giselle Post (UGent) , Bruno Speleers (UGent) , et al.

(2021) BREAST. 55. p.105-111

Add to list

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)

MEM van der Noordaa, FH van Duijnhoven, CE Loo, E van Werkhoven, Koen Van de Vijver (UGent) , T Wiersma, HAO Winter-Warnars, GS Sonke and MTFD Vrancken Peeters

(2018) BREAST. 40. p.76-81

Add to list

Physical activity levels after treatment for breast cancer : two-year follow-up

An De Groef, Inge Geraerts, Heleen Demeyer (UGent) , Elien Van der Gucht, Lore Dams, Carlijn de Kinkelder, Sanne Dukers-van Althuis, Marijke Van Kampen and Nele Devoogdt

(2018) BREAST. 40. p.23-28

Academic Bibliography

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial.

Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial

Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)

Physical activity levels after treatment for breast cancer : two-year follow-up

Contents

Support

Contact